Esteban Lizárraga-Cepeda
Research Subjects
Esteban Lizárraga-Cepeda has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Alcázar Juárez
División de Ciencias de la Salud, Universidad de Monterrey, 66238 San Pedro Garza García, Nuevo León, Mexico
1 shared publication - David Basurto
Department of Development and Regeneration, Cluster Woman and Child, Biomedical Sciences, My FetUZ Fetal Research Center, KU Leuven, Leuven, Belgium
1 shared publication - Gerardo Sepúlveda González
Medicina y Cirugía Fetal Monterrey, 66267 San Pedro Garza García, Nuevo León, Mexico
1 shared publication - Iván Vladimir Dávila-Escamilla
Department of Gynecology and Obstetrics, Facultad de Medicina, Hospital Universitario, Universidad Autónoma de Nuevo León (UANL), Monterrey 64440, Mexico
1 shared publication - Tayde Arroyo-Lemarroy
Hospital Regional de Alta Especialidad Materno Infantil de Nuevo León
1 shared publication - Ángel Regino Guerra de la Garza Evia
Instituto Tecnológico y de Estudios Superiores de Monterrey, 64849 Monterrey, Nuevo León, Mexico
1 shared publication
Latest Publications
- Open Access
- 22 November 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (11) , 986
Intracranial Translucency, Its Use as a Potential First Trimester Ultrasound Marker for Screening of Neural Tube Defects
The objective of the study was to describe a case-series of neural tube defects (NTD) with an abnormal intracranial translucency (IT) detected during the first-trimester ultrasound scan, performed on a low-risk obstetric population in Mexico. Certified Fetal Medicine specialists performed all US scans; the IT was assessed using the mid-sagittal view of the fetal head, which is already systematically used for nuchal translucency and nasal bone evaluation. During the study, we were able to find that eight fetuses had an absence of the intracranial translucency, out of which two were reassessed at 14 weeks′ gestation and IT was normal, six of them were later diagnosed to have an NTD that consisted in spina bifida aperta (n = 5) and encephalocele (n = 1). Conclusion: As previous studies have shown, IT evaluation during the first-trimester US routine scan may be a useful screening marker for early detection of NTDs.
- 22 November 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (11) , 986
Open AccessIntracranial Translucency, Its Use as a Potential First Trimester Ultrasound Marker for Screening of Neural Tube Defects
The objective of the study was to describe a case-series of neural tube defects (NTD) with an abnormal intracranial translucency (IT) detected during the first-trimester ultrasound scan, performed on a low-risk obstetric population in Mexico. Certified Fetal Medicine specialists performed all US scans; the IT was assessed using the mid-sagittal view of the fetal head, which is already systematically used for nuchal translucency and nasal bone evaluation. During the study, we were able to find that eight fetuses had an absence of the intracranial translucency, out of which two were reassessed at 14 weeks′ gestation and IT was normal, six of them were later diagnosed to have an NTD that consisted in spina bifida aperta (n = 5) and encephalocele (n = 1). Conclusion: As previous studies have shown, IT evaluation during the first-trimester US routine scan may be a useful screening marker for early detection of NTDs.